Adeline Boulanger (Paul Frank + Collins P.C.) |
Alberto Haddad (Mj & Cie) |
Alexandra Suhas (Zedra Global Expansion Us) |
Alexia Sibony (Mindmaze) |
Anne Moulin (Domes Pharma Us Inc.) |
Aude Ouensanga (Alira Health) |
Bernard Malfroy-Camine (Mindset Rx) |
Carin Knoop (Harvard Business School) |
Catherine Chaulet (Global Dmc Partners) |
Charlie Attlan (Boston Scientific) |
Christophe Arbet-Engels (Millendo Therapeutics) |
Delphine Zurkiya (Mckinsey) |
Eric Pité (Posit) |
Frederic Nicol (Takeda) |
Helenn Lemaistre (Credit Mutuel Equity) |
Herve Seux (Investor) |
Jean-Charles Wirth (Milliporesigma (Merck Kgaa)) |
Jean-Jacques Yarmoff (Mmld) |
Jean-Marc Peallat (Automation Engineering Inc) |
Jean-Pierre Sommadossi (Atea Pharmaceuticals) |
Joel Berniac (Biofuturis, Llc) |
Linda Kassa Hote (Teamwork Us) |
Loredana Vieil (Ernst & Young) |
Nicolas De Beco (Quadient) |
Patrick Millot (Laticrete) |
Patrick Tricoli (Nanobiotix) |
Philippe Gassin (Optics 1) |
Philippe Lopes-Fernandes (Ipsen) |
Philippe Mourere (Stilla Technologies) |
Philippe Sauvage (Sanofi) |
Philippe Suhas (Axelia Partners) |
Pierre Matte (Stmicroelectronics) |
Renaud Megard (Nfi Corp) |
Romain Marmot (Aptar) |
Thierry Bernard (Qiagen) |
Valerie Philippon (Takeda) |
Vincent Geffray (Everbridge) |
Vincent Hennemand (Intergalactic Therapeutics) |
Xavier Touret (Natixis) |
Yannick Wittner (Dassault Systemes) |
